Psychopathology and Cognition in 22q11 CNV disorders

Completed

• Conditions: 22q111 CNV disorders; disorders of chromosome 22; 10083624; 10039628

• Registration Number: NL-OMON47626
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
-A deletion or duplication at chromosome 22q11 confirmed by FISH, micro-array
or MLPA analysis.
-ability to give informed consent
-Written informed consent by participant
-Age 18 -65 years

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded
from participation in this study:
-chromosomal abnormalities other than 22q11 CNVs

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Neuropsychological outcome measures (working memory, attention, social<br /><br>cognition,verbal memory, processing speed, visual memory, planning), a<br /><br>cognitive composite score bases on the total score of the CANTAB subtests<br /><br>(representing cognitive function), IQ, psychiatric diagnosis</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n/a</p><br>